People: Regeneron Pharmaceuticals Inc (REGN.O)
259.49USD
12:25pm EDT
$-2.93 (-1.12%)
$262.42
$257.43
$260.47
$245.52
507,782
1,106,289
$283.99
$107.31
LaRosa, Joseph
Brief Biography
Mr. Joseph J. LaRosa is Senior Vice President, General Counsel, Secretary of Regeneron Pharmaceuticals, Inc., since September 06, 2011. From 1993 to 2009, Mr. LaRosa held a number of senior legal positions at Schering-Plough Corporation, where he was a corporate officer and served most recently as Vice President, Legal Affairs, and a member of the Operations Management Team. He also served as Vice President, Global Compliance and Legal Affairs at Avon Products, Inc. Most recently Mr. LaRosa was Senior Vice President, General Counsel and Secretary at Nycomed US Inc. Mr. LaRosa received his J.D. from New York University School of Law.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
P. Roy Vagelos |
-- |
Leonard Schleifer |
30,047,100 |
Murray Goldberg |
9,623,070 |
Joseph LaRosa |
-- |
Daniel Van Plew |
2,188,990 |
Peter Powchik |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
